Soros, Gates back medtech's move into a 'social enterprise'; Aging anti-rejection drug earns fresh approval
George Soros and Bill Gates are teaming up to buy out a British diagnostics company.
The pair and their foundations will spend about $41 million …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
